Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Albert David Ltd ( (IN:ALBERTDAVD) ) just unveiled an update.
Albert David Ltd has disclosed that it received a request from investor Bharat Kumar N Jain for transfer of 300 physical equity shares into his name, relating to securities previously purchased but not transferred. In line with SEBI guidelines on transfer of physical securities, the company has invited any counterclaims from potential claimants within 30 days, after which it will proceed with the transfer if no valid objections are received.
To comply with regulatory requirements and ensure transparency, Albert David has published details of this re-lodgement of share transfer in the March 13, 2026 editions of Financial Express and Aajkal. The move underscores the company’s adherence to SEBI’s investor protection framework and formalizes the process for resolving ownership of legacy physical share certificates before completing the transfer to the requesting investor.
More about Albert David Ltd
Albert David Ltd is an Indian pharmaceutical company listed on BSE and NSE, engaged in manufacturing and marketing formulations and healthcare products. Its equity shares are actively traded in the domestic capital markets, and the company is subject to Securities and Exchange Board of India (SEBI) regulations governing share transfers and investor protection.
Average Trading Volume: 247
Technical Sentiment Signal: Hold
Current Market Cap: 3.91B INR
For a thorough assessment of ALBERTDAVD stock, go to TipRanks’ Stock Analysis page.